Autobahn Labs is a collaboration between a Samsara BioCapital-led investor syndicate and Charles River Laboratories. By combining Samsara's long-term investment philosophy with Charles River's world-class drug discovery and development capabilities we believe we can improve patient health by identifying exciting early-stage academic research projects that can spark the development of new therapeutics.